Abstract
BackgroundGiven FDA warnings, drug holidays (temporary or permanent discontinuation) of bisphosphonates (BPs) after long-term (3–5 years) continuous therapy is becoming increasingly common in the United States (US). However, the benefits...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have